skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

About Nielsen

Washington DC, {6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+24 year(s) experience

Nielsen has more than 20 years of experience covering the pharmaceutical industry, and writes frequently about the intersection of business, regulation, science and politics. Before joining Pink Sheet, he worked for Congressional Quarterly.
As Executive Editor, US Regulatory and Policy, Nielsen leads Pink Sheet’s US coverage and collaborates across Informa Pharma Intelligence’s publications. He supports the insightful news and deep analysis on how to get your product developed, approved, and reimbursed, and oversees Pink Sheet’s team of reporters who are experts on everything from ANDAs to Zika vaccines, offering lively stories that help subscribers understand the personalities, policies, and pain points that dictate whether their regulatory strategy succeeds or fails. Features such as the FDA Performance Tracker and Drug Review Profiles illuminate the inner workings of the agency.

Nielsen is a frequent speaker and moderator at industry conferences, and enjoys discussing BB-8 almost as much as he enjoys talking about 351(k).

Specialties

  • Policy & Regulation
  • Generics

Nielsen Writes For

Analyst Articles

Articles by Nielsen